By Dave Harrison
March 2, 2016, Toronto — Bedrocan Canada, wholly owned subsidiary of Canopy Growth Corporation is offering vaporizers at cost as part of its commitment to affordable medical cannabis treatment.
The offer, available to all registered Bedrocan Canada clients, is a part of a wider effort to reduce the cost of medicating with cannabis.
“Bedrocan is fully engaged with the medical community and respects the concern many physicians have with inhaling burnt plant matter as a means to medicate,” said company president Marc Wayne. “Offering deep discounts on vaporizers is a way to address this concern by making alternative therapy applications more affordable.”
Bedrocan Canada already offers the most affordable full line of standardized cannabis varieties in the country. Via True Compassionate Pricing, all Bedrocan varieties cost $5 per gram for all registered clients.
“Bedrocan Canada is and will always be a medical cannabis company,” said Bruce Linton, CEO of Canopy Growth.
“Canada’s cannabis laws are evolving but Bedrocan Canada is focused on advancements on the medical side of the industry. By advocating for tax amendments, coordinating research initiatives and facilitating physician education, the team at Bedrocan Canada remains focused on its core business.”
To learn more about Bedrocan Canada’s vaporizer selection and pricing, visit www.bedrocan.ca.